Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Neurosensory Account of Anxiety and Stress (Study 2)

NCT: NCT07079839 · RECRUITING

NCT IDNCT07079839
StatusRECRUITING
Start Date2025-07-03
Completion2027-06
SponsorThe University of Texas Health Science Center, Houston (OTHER)
First posted
Last updated

Brief Summary

This study will take a basic neuroscience approach to investigate pathological mechanisms underlying PTSD. Additionally, the study aims to identify how Transcranial Alternating Current Stimulation (tACS) brain stimulation can modulate and correct neural networks and related emotions of anxious arousal and hypervigilance, with the goal of assessing tACS brain stimulation technology as a novel intervention for symptoms of anxiety.

Frequently Asked Questions

What is A Neurosensory Account of Anxiety and Stress (Study 2)?

A Neurosensory Account of Anxiety and Stress (Study 2) is a clinical trial registered under NCT07079839. Current status: RECRUITING.

What is the status of NCT07079839?

The current status of NCT07079839 (A Neurosensory Account of Anxiety and Stress (Study 2)) is: RECRUITING.

When did A Neurosensory Account of Anxiety and Stress (Study 2) start?

A Neurosensory Account of Anxiety and Stress (Study 2) started on 2025-07-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.